Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cetirizine dihydrochloride - tablets - cetirizine dihydrochloride 10 mg - cetirizine - cetirizine - antihistaminic drug for the treatment of allergies. for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cabergoline - tablets - cabergoline 0.5 mg - dopa and dopa derivatives - treatment of hyperprolactinemic disorders.cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cetirizine dihydrochloride - tablets - cetirizine dihydrochloride 10 mg - cetirizine - antihistaminic drug for the treatment of allergies. for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - imatinib - trima is indicated for the• treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase, accelerated phase or blast crisis.• treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). • adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.• treatment of adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. • treatment of adult patients with relapsed or refractory ph+ all as monotherapy. • treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery.• treatment of adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet-derived growth factor receptor) gene re-arrangements. • treatment of adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1-pdgfrα fusion kinase (mutational analysis or fish demonstration of chic2 allele deletion) and for patients with hes and/or cel who are fip1l1- pdgfrα fusion kinase negative. • treatment of adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - imatinib-trima is indicated for the• treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase, accelerated phase or blast crisis.• treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). • adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.• treatment of adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. • treatment of adult patients with relapsed or refractory ph+ all as monotherapy. • treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery.• treatment of adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet-derived growth factor receptor) gene re-arrangements. • treatment of adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1-pdgfrα fusion kinase (mutational analysis or fish demonstration of chic2 allele deletion) and for patients with hes and/or cel who are fip1l1- pdgfrα fusion kinase negative. • treatment of adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - loratadine - syrup - loratadine 0.1 g / 100 ml - loratadine - antihistamine preparation for treatment of allergic rhinitis and urticaria.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - oral drops - dimetindene maleate 1 mg / 1 ml - dimetindene - antipruritic, antihistaminic and antiallergic.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - gentamicin as sulfate - cream - gentamicin as sulfate 0.10 %w/w - gentamicin - gentamicin - for the treatment of wounds, burns, acne spots and dermatoses infected with bacteria sensitive to gentamycin.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - gentamicin as sulfate - cream - gentamicin as sulfate 0.10 %w/w - gentamicin - gentamicin - for the treatment of wounds, burns, acne spots and dermatoses infected with bacteria sensitive to gentamycin.

Iżrael - Ingliż - Ministry of Health

trima israel pharmaceutical products maabarot ltd - gentamicin as sulfate - ointment - gentamicin as sulfate 0.10 %w/w - gentamicin - gentamicin - for the treatment of wounds, burns, acne spots and dermatoses infected with bacteria sensitive to gentamycin.